Location History:
- Basle, CH (1994)
- Basel, CH (1997)
Company Filing History:
Years Active: 1994-1997
Title: The Innovations of Roger Clerc
Introduction
Roger Clerc is a notable inventor based in Basle, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of human macrophage migration inhibition factor. With a total of two patents to his name, his work has implications for diagnostic methods related to inflammatory conditions and cystic fibrosis.
Latest Patents
Clerc's latest patents include innovations concerning polypeptides related to human macrophage migration inhibition factor. The first patent focuses on DNAS encoding for these polypeptides, specifically MRP-8 and MRP-14. This invention encompasses processes for their preparation, mRNAs, DNAs, and hybrid vectors coding for these polypeptides. It also includes hosts transformed with such hybrid vectors, as well as monoclonal and polyclonal antibodies to these polypeptides. The second patent similarly addresses antibodies that bind to novel lymphokine-related peptides, further emphasizing the importance of MRP-8 and MRP-14 in diagnostic methods for inflammatory conditions and cystic fibrosis.
Career Highlights
Throughout his career, Roger Clerc has worked with prominent companies such as Ciba-Geigy Corporation and Novartis Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical diagnostics and treatment.
Collaborations
Clerc has collaborated with notable colleagues, including Karel Gerrit Odink and Nico Cerletti. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions in the field.
Conclusion
Roger Clerc's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatment options.